Advanced search
Publication Cover
Journal of Pain & Palliative Care Pharmacotherapy Volume 24, 2010 - Issue 4
Submit an article Journal homepage
247
Views
10
CrossRef citations to date
0
Altmetric
PAIN MANAGEMENT IN PRIMARY CARE

Gout: Nonsteroidal Anti-inflammatory Drugs and Colchicine to Prevent Painful Flares During Early Urate-Lowering Therapy

Louis Kuritzky Louis Kuritzky, MD, is Clinical Assistant Professor, Department of Community Health & Family, and is with the Family Medicine Residency Program, University of Florida, Gainesville, Florida, USA. Rishi Panchal, BS, is a medical student at the Midwestern University School of Osteopathic Medicine, Phoenix, AZ, USA.
&
Rishi Panchal Louis Kuritzky, MD, is Clinical Assistant Professor, Department of Community Health & Family, and is with the Family Medicine Residency Program, University of Florida, Gainesville, Florida, USA. Rishi Panchal, BS, is a medical student at the Midwestern University School of Osteopathic Medicine, Phoenix, AZ, USA.
Pages 397-401 | Published online: 06 Dec 2010

REFERENCES

  • Wortmann RL. Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol. 2005;17:319–324.
  • Singh H. Diagnosis and management of gout in the long-term care setting. Ann Long Term Care. 2007;15 (4):22–26.
  • Ferraz MB. An evidence based appraisal of the management of nontophaceous interval gout. J Rheumatol. 1995;22: (9): 1621–3.
  • Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312–1324.
  • Eggebeen AT. Gout: an update. Am Fam Physician. 2007;76: 801–808, 811–812.
  • Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis. 2002;40:37–42.
  • Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31:1582–1587.
  • Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol. 2004;31:2429–2432.
  • Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51:321–325.
  • Rubinstein BK, Wise CM. Hyperuricemia and gout. In: E. T. Bope, R. E. Rakel, R. Kellerman (Eds.). Conn's Current Therapy. Philadelphia: WB Saunders; 2010: 605–608.
  • Becker MA, Schumacher R, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Febuxostat compared with allopurinol in patients with hyperricemia and gout. N Engl J Med. 2006;354:2450–2461.
  • Terkeltaub R. Cecil Textbook of Medicine. 22nd ed (L. Goldman, D. Ausiello, Eds.) (pp. 1703–1710). Philadelphia: WB Saunders; 2004.
  • Schumacher HR, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ. 2002;324:1488–1492.
  • Becker MA. Treatment of acute gout. UptoDate version 18.1: January 2010.
  • Naprosyn. Prescribing information, 2010. Physicians Desk-Reference. Manufacturer: Roche.
  • Fennerty B. NSAID-related gastronintestinal injury. Evidence-based approach to a preventable complication. Postgrad Med. 2001;110:91–94.
  • Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B):31–8S.
  • Celebrex. Prescribing information, 2010. Physicians Desk-Reference. Manufacturer: Searle.
  • Ben-Chetrit E, Levy M. Colchicine prophylaxis in FMF: reappraisal after 15 years. Semin Arthritis Rheum. 1991;20:241–248.
  • Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum. 2009;38:411–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.